Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 May;31(5):675–678. doi: 10.1128/aac.31.5.675

Liposomes as carriers of antimicrobial agents.

G Lopez-Berestein
PMCID: PMC174813  PMID: 3300535

Full text

PDF
675

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alving C. R., Steck E. A., Chapman W. L., Jr, Waits V. B., Hendricks L. D., Swartz G. M., Jr, Hanson W. L. Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. Life Sci. 1980 Jun 30;26(26):2231–2238. doi: 10.1016/0024-3205(80)90207-6. [DOI] [PubMed] [Google Scholar]
  2. Alving C. R., Steck E. A., Hanson W. L., Loizeaux P. S., Chapman W. L., Jr, Waits V. B. Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug. Life Sci. 1978 Mar;22(12):1021–1026. doi: 10.1016/0024-3205(78)90270-9. [DOI] [PubMed] [Google Scholar]
  3. Alving C. R., Swartz G. M., Jr, Hendricks L. D., Chapman W. L., Jr, Waits V. B., Hanson W. L. Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters. Ann Trop Med Parasitol. 1984 Jun;78(3):279–286. doi: 10.1080/00034983.1984.11811817. [DOI] [PubMed] [Google Scholar]
  4. Andreoli T. E. The structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes. Ann N Y Acad Sci. 1974 May 10;235(0):448–468. doi: 10.1111/j.1749-6632.1974.tb43283.x. [DOI] [PubMed] [Google Scholar]
  5. Bakker-Woudenberg I. A., Lokerse A. F., Vink-van den Berg J. C., Roerdink F. H., Michel M. F. Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages. Antimicrob Agents Chemother. 1986 Aug;30(2):295–300. doi: 10.1128/aac.30.2.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bonventre P. F., Gregoriandis G. Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimicrob Agents Chemother. 1978 Jun;13(6):1049–1051. doi: 10.1128/aac.13.6.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chapman W. L., Jr, Hanson W. L., Alving C. R., Hendricks L. D. Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog. Am J Vet Res. 1984 May;45(5):1028–1030. [PubMed] [Google Scholar]
  8. Christiansen K. J., Bernard E. M., Gold J. W., Armstrong D. Distribution and activity of amphotericin B in humans. J Infect Dis. 1985 Nov;152(5):1037–1043. doi: 10.1093/infdis/152.5.1037. [DOI] [PubMed] [Google Scholar]
  9. DeGregorio M. W., Lee W. M., Linker C. A., Jacobs R. A., Ries C. A. Fungal infections in patients with acute leukemia. Am J Med. 1982 Oct;73(4):543–548. doi: 10.1016/0002-9343(82)90334-5. [DOI] [PubMed] [Google Scholar]
  10. Desiderio J. V., Campbell S. G. Intraphagocytic killing of Salmonella typhimurium by liposome-encapsulated cephalothin. J Infect Dis. 1983 Sep;148(3):563–570. doi: 10.1093/infdis/148.3.563. [DOI] [PubMed] [Google Scholar]
  11. Desiderio J. V., Campbell S. G. Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis. J Reticuloendothel Soc. 1983 Oct;34(4):279–287. [PubMed] [Google Scholar]
  12. Fraser-Smith E. B., Eppstein D. A., Larsen M. A., Matthews T. R. Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection. Infect Immun. 1983 Jan;39(1):172–178. doi: 10.1128/iai.39.1.172-178.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gabizon A., Dagan A., Goren D., Barenholz Y., Fuks Z. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res. 1982 Nov;42(11):4734–4739. [PubMed] [Google Scholar]
  14. Gold J. W. Opportunistic fungal infections in patients with neoplastic disease. Am J Med. 1984 Mar;76(3):458–463. doi: 10.1016/0002-9343(84)90665-x. [DOI] [PubMed] [Google Scholar]
  15. Graybill J. R., Craven P. C., Taylor R. L., Williams D. M., Magee W. E. Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis. 1982 May;145(5):748–752. doi: 10.1093/infdis/145.2.748. [DOI] [PubMed] [Google Scholar]
  16. Hamilton-Miller J. M. Chemistry and biology of the polyene macrolide antibiotics. Bacteriol Rev. 1973 Sep;37(3):166–196. [PMC free article] [PubMed] [Google Scholar]
  17. Koff W. C., Fidler I. J., Showalter S. D., Chakrabarty M. K., Hampar B., Ceccorulli L. M., Kleinerman E. S. Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells. Science. 1984 Jun 1;224(4652):1007–1009. doi: 10.1126/science.6426057. [DOI] [PubMed] [Google Scholar]
  18. Koff W. C., Fidler I. J. The potential use of liposome-mediated antiviral therapy. Antiviral Res. 1985 Jun;5(3):179–190. doi: 10.1016/0166-3542(85)90050-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Koff W. C., Showalter S. D., Seniff D. A., Hampar B. Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma. Infect Immun. 1983 Dec;42(3):1067–1072. doi: 10.1128/iai.42.3.1067-1072.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lopez-Berestein G., Bodey G. P., Frankel L. S., Mehta K. Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. J Clin Oncol. 1987 Feb;5(2):310–317. doi: 10.1200/JCO.1987.5.2.310. [DOI] [PubMed] [Google Scholar]
  21. Lopez-Berestein G., Fainstein V., Hopfer R., Mehta K., Sullivan M. P., Keating M., Rosenblum M. G., Mehta R., Luna M., Hersh E. M. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis. 1985 Apr;151(4):704–710. doi: 10.1093/infdis/151.4.704. [DOI] [PubMed] [Google Scholar]
  22. Lopez-Berestein G., Hopfer R. L., Mehta R., Mehta K., Hersh E. M., Juliano R. L. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis. 1984 Aug;150(2):278–283. doi: 10.1093/infdis/150.2.278. [DOI] [PubMed] [Google Scholar]
  23. Lopez-Berestein G., Kasi L., Rosenblum M. G., Haynie T., Jahns M., Glenn H., Mehta R., Mavligit G. M., Hersh E. M. Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. Cancer Res. 1984 Jan;44(1):375–378. [PubMed] [Google Scholar]
  24. Lopez-Berestein G., McQueen T., Mehta K. Protective effect of liposomal-amphotericin B against C. albicans infection in mice. Cancer Drug Deliv. 1985 Summer;2(3):183–189. doi: 10.1089/cdd.1985.2.183. [DOI] [PubMed] [Google Scholar]
  25. Lopez-Berestein G., Mehta R., Hopfer R. L., Mills K., Kasi L., Mehta K., Fainstein V., Luna M., Hersh E. M., Juliano R. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis. 1983 May;147(5):939–945. doi: 10.1093/infdis/147.5.939. [DOI] [PubMed] [Google Scholar]
  26. Lopez-Berestein G., Mehta R., Hopfer R., Mehta K., Hersh E. M., Juliano R. Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Cancer Drug Deliv. 1983;1(1):37–42. doi: 10.1089/cdd.1983.1.37. [DOI] [PubMed] [Google Scholar]
  27. Lopez-Berestein G., Milas L., Hunter N., Mehta K., Hersh E. M., Kurahara C. G., Vandupas M., Eppstein D. A. Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine. Clin Exp Metastasis. 1984 Apr-Jun;2(2):127–137. doi: 10.1007/BF00052413. [DOI] [PubMed] [Google Scholar]
  28. Lopez-Berestein G., Rosenblum M. G., Mehta R. Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. Cancer Drug Deliv. 1984 Summer;1(3):199–205. doi: 10.1089/cdd.1984.1.199. [DOI] [PubMed] [Google Scholar]
  29. Maksymiuk A. W., Thongprasert S., Hopfer R., Luna M., Fainstein V., Bodey G. P. Systemic candidiasis in cancer patients. Am J Med. 1984 Oct 30;77(4D):20–27. [PubMed] [Google Scholar]
  30. Mehta K., Claringbold P., Lopez-Berestein G. Amphotericin B inhibits the serum-induced expression of tissue transglutaminase in murine peritoneal macrophages. J Immunol. 1986 Jun 1;136(11):4206–4212. [PubMed] [Google Scholar]
  31. Mehta R. T., Mehta K., Lopez-Berestein G., Juliano R. L. Effect of liposomal amphotericin B on murine macrophages and lymphocytes. Infect Immun. 1985 Feb;47(2):429–433. doi: 10.1128/iai.47.2.429-433.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mehta R., Lopez-Berestein G., Hopfer R., Mills K., Juliano R. L. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim Biophys Acta. 1984 Mar 14;770(2):230–234. doi: 10.1016/0005-2736(84)90135-4. [DOI] [PubMed] [Google Scholar]
  33. Morgan J. R., Williams K. E. Preparation and properties of liposome-associated gentamicin. Antimicrob Agents Chemother. 1980 Apr;17(4):544–548. doi: 10.1128/aac.17.4.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. New R. R., Chance M. L., Heath S. Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. J Antimicrob Chemother. 1981 Nov;8(5):371–381. doi: 10.1093/jac/8.5.371. [DOI] [PubMed] [Google Scholar]
  35. New R. R., Chance M. L., Thomas S. C., Peters W. Antileishmanial activity of antimonials entrapped in liposomes. Nature. 1978 Mar 2;272(5648):55–56. doi: 10.1038/272055a0. [DOI] [PubMed] [Google Scholar]
  36. Panosian C. B., Barza M., Szoka F., Wyler D. J. Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B. Antimicrob Agents Chemother. 1984 May;25(5):655–656. doi: 10.1128/aac.25.5.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pirson P., Steiger R. F., Trouet A., Gillet J., Herman F. Primaquine liposomes in the chemotherapy of experimental murine malaria. Ann Trop Med Parasitol. 1980 Aug;74(4):383–391. doi: 10.1080/00034983.1980.11687359. [DOI] [PubMed] [Google Scholar]
  38. Pirson P., Steiger R., Trouet A. The disposition of free and liposomally encapsulated antimalarial primaquine in mice. Biochem Pharmacol. 1982 Nov 1;31(21):3501–3507. doi: 10.1016/0006-2952(82)90633-5. [DOI] [PubMed] [Google Scholar]
  39. Taylor R. L., Williams D. M., Craven P. C., Graybill J. R., Drutz D. J., Magee W. E. Amphotericin B in liposomes: a novel therapy for histoplasmosis. Am Rev Respir Dis. 1982 May;125(5):610–611. doi: 10.1164/arrd.1982.125.5.610. [DOI] [PubMed] [Google Scholar]
  40. Vladimirskii M. A., Strel'tsov V. P., Stapanov V. M., Braude V. I. Liposomy kak nositel' protivotuberkuleznykh preparatov - novyi podkhod v éksperimental'noi khimioterapii tuberkuleza. Probl Tuberk. 1980 Jul;(7):53–56. [PubMed] [Google Scholar]
  41. Weldon J. S., Munnell J. F., Hanson W. L., Alving C. R. Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway. Z Parasitenkd. 1983;69(4):415–424. doi: 10.1007/BF00927697. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES